18F-PF-06445974

N/A

Report date: 2026/02/18 20:02:09
NME

Base Information

Drug Name18F-PF-06445974
Drug Alias Name18F-PF-0644597418-F-PF-06445974
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 4B inhibitors
TargetsPhosphodiesterase 4B
Therapy Area/IndicationsCognitive DysfunctionDepressionAlcoholism +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Mental Health (Nimh)
Inactive CompaniesPfizer Inc
Active IndicationsCognitive DysfunctionDepressionAlcoholism +[4] 
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A